Institute of Radiology, University Hospital Erlangen, Germany.
Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, PSI Villigen, Switzerland.
Radiother Oncol. 2018 Jul;128(1):109-114. doi: 10.1016/j.radonc.2018.01.018. Epub 2018 Feb 17.
To derive the dose-response curve for temporal lobe reactions (TLRs) after proton therapy and to compare the resulting relative biological effectiveness (RBE)-weighted tolerance doses based on an RBE of 1.1 with published values for carbon ions, which were calculated by the two versions of the local effect model (LEM I or IV).
62 patients treated with protons for skull base tumors were analyzed for TLRs using magnetic resonance imaging. Within the mean follow-up time of 38 months, TLRs were observed in six patients. Dose-response curves based on the RBE-weighted maximum dose, excluding the 1 cm-volume with the highest dose, were derived and compared to previously published dose-response curves for carbon ions, which were obtained using LEM I or IV, respectively.
The dose-response curves for protons and LEM I were found to be almost identical while the curve of LEM IV was shifted toward higher doses. The resulting tolerance doses at the 5% effect level were 68.2, 68.6 and 78.3 Gy (RBE), respectively.
The RBE-weighted dose prescription for protons leads to the same RBE-weighted dose-response curve for TLR as the one for LEM I-based carbon ions, while LEM IV predicts clinically significant higher tolerance doses.
推导出质子治疗后颞叶反应(TLRs)的剂量-反应曲线,并将基于 1.1 的相对生物效应(RBE)加权耐受剂量与基于局部效应模型(LEM I 或 IV)的碳离子公布值进行比较。
对 62 名接受质子治疗颅底肿瘤的患者进行了 TLRs 的磁共振成像分析。在平均随访时间为 38 个月内,有 6 名患者出现了 TLRs。基于 RBE 加权最大剂量(不包括剂量最高的 1cm 体积)推导了剂量-反应曲线,并与之前使用 LEM I 或 IV 分别获得的碳离子剂量-反应曲线进行了比较。
发现质子和 LEM I 的剂量-反应曲线几乎相同,而 LEM IV 的曲线则向更高的剂量偏移。在 5%效应水平下的耐受剂量分别为 68.2、68.6 和 78.3Gy(RBE)。
质子的 RBE 加权剂量处方导致 TLR 的 RBE 加权剂量-反应曲线与基于 LEM I 的碳离子相同,而 LEM IV 预测的耐受剂量临床意义更高。